Exagen inc. to participate in the canaccord genuity 43rd annual growth conference

San diego, july 26, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the canaccord genuity 43rd annual growth conference, which takes place august 7-10, 2023, at the intercontinental boston hotel in boston, ma. john aballi, exagen's president and chief executive officer and kamal adawi, exagen's chief financial officer, will present on wednesday, august 9th, at 3:00 pm et. interested parties may access the webcast of the presentation using a link on exagen's website at https://investors.exagen.com/events.
XGN Ratings Summary
XGN Quant Ranking